About Us
The Office of Health Economics provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.
Our expertise covers:
- national and international public policy health care issues
- the financing and organisation of health care
- competitiveness, regulation and structure of the pharmaceutical industry
- pharmaceutical industry economics
- pricing and reimbursement of pharmaceuticals
- cost-effectiveness evaluation of health care technology
The OHE has an international reputation, for the quality and independence of its research, which is safeguarded through our Policy Board and Editorial Board.
The Office of Health Economics (OHE) was founded in 1962. Its terms of reference are to:
- commission and undertake research on the economics of health and health care
- collect and analyse health and health care data for the UK and other countries
- disseminate the results of this work and stimulate discussion of them and their policy implications
The OHE is supported by an annual grant from the Association of the British Pharmaceutical Industry and by sales of its publications, and welcomes financial support from other bodies interested in its work.